Emmy Boerrigter (E Boerrigter)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Radical Prostatectomy

Circulating Tumor

Prostate Cancer

Top Venues

Nature communications

British journal of clinical pharmacology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Andrew J Murtha, Catarina Kollmannsberger, Edmond M Kwan, Karan Parekh, Elena Schönlau, Cecily Q Bernales, Gráinne Donnellan, Sarah W S Ng, Takayuki Sumiyoshi, Joanna Vergidis, Krista Noonan, Daygen L Finch, Muhammad Zulfiqar, Stacy Miller, Sunil Parimi, Jean-Michel Lavoie, Edward Hardy, Maryam Soleimani, Lucia Nappi, Bernhard J Eigl, Christian Kollmannsberger, Sinja Taavitsainen, Matti Nykter, Sofie H Tolmeijer, Emmy Boerrigter, Niven Mehra, Nielka P van Erp, Bram De Laere, Johan Lindberg, Henrik Gronberg, Daniel J Khalaf, Matti Annala, Kim N Chi, Alexander W Wyatt
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer. Nature communications 15 (1) (2024)
Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Andrew J Murtha, Catarina Kollmannsberger, Edmond M Kwan, Karan Parekh, Elena Schönlau, Cecily Q Bernales, Gráinne Donnellan, Sarah W S Ng, Takayuki Sumiyoshi, Joanna Vergidis, Krista Noonan, Daygen L Finch, Muhammad Zulfiqar, Stacy Miller, Sunil Parimi, Jean-Michel Lavoie, Edward Hardy, Maryam Soleimani, Lucia Nappi, Bernhard J Eigl, Christian Kollmannsberger, Sinja Taavitsainen, Matti Nykter, Sofie H Tolmeijer, Emmy Boerrigter, Niven Mehra, Nielka P van Erp, Bram De Laere, Johan Lindberg, Henrik Gronberg, Daniel J Khalaf, Matti Annala, Kim N Chi, Alexander W Wyatt
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer. Nature communications 15 (1) (2024)
Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Andrew J Murtha, Catarina Kollmannsberger, Edmond M Kwan, Karan Parekh, Elena Schönlau, Cecily Q Bernales, Gráinne Donnellan, Sarah W S Ng, Takayuki Sumiyoshi, Joanna Vergidis, Krista Noonan, Daygen L Finch, Muhammad Zulfiqar, Stacy Miller, Sunil Parimi, Jean-Michel Lavoie, Edward Hardy, Maryam Soleimani, Lucia Nappi, Bernhard J Eigl, Christian Kollmannsberger, Sinja Taavitsainen, Matti Nykter, Sofie H Tolmeijer, Emmy Boerrigter, Niven Mehra, Nielka P van Erp, Bram De Laere, Johan Lindberg, Henrik Gronberg, Daniel J Khalaf, Matti Annala, Kim N Chi, Alexander W Wyatt
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer. Nature communications 15 (1) (2024)
Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Andrew J Murtha, Catarina Kollmannsberger, Edmond M Kwan, Karan Parekh, Elena Schönlau, Cecily Q Bernales, Gráinne Donnellan, Sarah W S Ng, Takayuki Sumiyoshi, Joanna Vergidis, Krista Noonan, Daygen L Finch, Muhammad Zulfiqar, Stacy Miller, Sunil Parimi, Jean-Michel Lavoie, Edward Hardy, Maryam Soleimani, Lucia Nappi, Bernhard J Eigl, Christian Kollmannsberger, Sinja Taavitsainen, Matti Nykter, Sofie H Tolmeijer, Emmy Boerrigter, Niven Mehra, Nielka P van Erp, Bram De Laere, Johan Lindberg, Henrik Gronberg, Daniel J Khalaf, Matti Annala, Kim N Chi, Alexander W Wyatt
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer. Nature communications 15 (1) (2024)
Emmy Boerrigter, Elise Joëlle Smolders
In depth: The drug interaction between trimethoprim-sulfamethoxazole and folic acid/folinic acid. British journal of clinical pharmacology 90 (8) (2024)
Emmy Boerrigter, Elise Joëlle Smolders
In depth: The drug interaction between trimethoprim-sulfamethoxazole and folic acid/folinic acid. British journal of clinical pharmacology (2024)
Eva Podgoršek, Niven Mehra, Inge M van Oort, Diederik M Somford, Emmy Boerrigter, Nielka P van Erp
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide. Clinical pharmacokinetics (2023)
Sofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, Edmond M Kwan, Sarah W S Ng, Matti Annala, Grainne Donnellan, Cameron Herberts, Guillemette E Benoist, Paul Hamberg, Diederik M Somford, Inge M van Oort, Jack A Schalken, Niven Mehra, Nielka P van Erp, Alexander W Wyatt
Early on-treatment changes in circulating tumor DNA fraction and response to enzalutamide or abiraterone in metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
S H Verhulst, Emmy Boerrigter, S Ras, N P van Erp, P Hamberg
Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic castration-resistant prostate cancer: a case report. Cancer chemotherapy and pharmacology 89 (4) (2022)
Emmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, Rogier Donders, Niven Mehra, Inge M van Oort, Rob Ter Heine, Nielka P van Erp
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer. British journal of clinical pharmacology (2021)
Emmy Boerrigter, Thomas Havenith, Nielka P van Erp, John-John B Schnog
Deep and ongoing response of castrate-resistant prostate cancer on very low-dose enzalutamide in an elderly chemotherapy-naïve patient: a case report. Cancer chemotherapy and pharmacology 88 (1) (2021)
Emmy Boerrigter, Guillemette E Benoist, Inge M van Oort, Gerald W Verhaegh, Onno van Hooij, Levi Groen, Frank Smit, Irma M Oving, Pieter de Mol, Tineke J Smilde, Diederik M Somford, Niven Mehra, Jack A Schalken, Nielka P van Erp
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment. Molecular oncology 15 (9) (2021)
Emmy Boerrigter, Guillemette E Benoist, Inge M van Oort, Gerald W Verhaegh, Anton F J de Haan, Onno van Hooij, Levi Groen, Frank Smit, Irma M Oving, Pieter de Mol, Tineke J Smilde, Diederik M Somford, Paul Hamberg, Vincent O Dezentjé, Niven Mehra, Nielka P van Erp, Jack A Schalken
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers 13 (24) (2021)